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We have developed a CCD-camera-based nonmydriatic instrument that detects fluorescence from retinal lipo- 
fuscin ehromophores (“autofluoreseenee”) as a means to indirectly quantify and spatially image the distribution 
of macular pigment (MP). The lipofuscin fluorescence intensity is reduced at all retinal locations containing 
MP, since MP has a competing absorption in the blue-green wavelength region. Projecting a large diameter, 
488 nm excitation spot onto the retina, centered on the fovea, but extending into the macular periphery, and 
comparing lipofuscin fluorescence intensities outside and inside the foveal area, it is possible to spatially map 
out the distribution of MP. Spectrally selective detection of the lipofuscin fluorescence reveals an important 
wavelength dependence of the obtainable image contrast and deduced MP optical density levels, showing that 
it is important to block out interfering fluorescence contributions in the detection setup originating from ocular 
media such as the lens. Measuring 70 healthy human volunteer subjects with no ocular pathologies, we find 
widely varying spatial extent of MP, distinctly differing distribution patterns of MP, and strongly differing ab­
solute MP levels among individuals. Our population study suggests that MP imaging based on lipofuscin fluo­
rescence is useful as a relatively simple, objective, and quantitative noninvasive optical technique suitable to 
rapidly screen MP levels and distributions in healthy humans with undilated pupils. © 2006 Optical Society 
of America
OCIS codes: 170.0170, 170.1610, 170.3890, 170.4580, 300.6450, 330.4300.
1. INTRODUCTION
Currently there is strong interest in developing noninva­
sive detection techniques for macular pigment (MP) in the 
living human retina. Composed of the carotenoid com­
pounds lutein and zeaxanthin, MP is thought to play a 
protective role in the prevention or delay o f age-related 
macular degeneration (AMD), the leading cause o f irre­
versible blindness in the elderly in the Western world . 1 ’ 2 
Epidemiological studies analyzing carotenoid levels via 
dietary surveys and serum assays have shown that there 
is an inverse correlation between high dietary intakes 
and blood levels of lutein and zeaxanthin and risk o f ad­
vanced AM D . 3 - 6  Furthermore, recent high performance 
liquid chromatography (HPLC) analysis of human ca­
daver eyes with and without a known history of AMD has 
demonstrated a correlation between levels of lutein and 
zeaxanthin and AMD , 7 and recent flicker photometry and 
resonance Raman clinical studies reached the same con­
clusion, although a reflectometry study did not . 8 - 1 0  The 
development o f noninvasive methods capable o f assessing 
MP levels in living humans, in particular objective meth­
ods that can quantify and spatially resolve MP distribu­
tions reliably and rapidly in large populations, would be 
o f tremendous benefit to epidemiological research on 
AMD. They could be used, for example, in large-scale
monitoring studies o f dietary and/or nutritional interven­
tions designed to raise MP levels, and they could poten­
tially help protect a large fraction o f the population from 
developing this debilitating disease.
MP is concentrated in the ~ 1-mm-diameter region o f 
the retina that provides high-acuity vision. It usually 
peaks in the center o f the macula, the foveola, and drops 
off rapidly with increasing eccentricity. Absolute concen­
trations of MP at this site are very high compared with 
those at other tissue sites, corresponding typically to 
10 -3 0  ng per macular punch biopsy (~ 5  mm diameter). 
The spectral absorption behavior is shown in Fig. 1 for an 
excised macula that was measured through a 1  mm aper­
ture; it shows that MP optical density levels in the peak of 
the absorption near 460 nm are typically very strong. In 
spite o f the very thin retinal tissue layer, the optical den­
sity reaches an average value of —0.3 above background, 
which explains the origin o f the strong yellow coloration 
of the macula. Comparing the optical absorption o f the 
macula with lutein and zeaxanthin solutions, one finds 
that the absorption behavior is remarkably similar, in­
cluding the appearance ofvibronic substructure, and that 
there is little overlap with potentially confounding other 
ehromophores in the intact retina . 11
Optical excitation o f MP leads to only very weak fluo-
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Fig. 1. (a) Absorption spectrum of an excised, flat-mounted, hu­
man retina in the blue-green wavelength region, showing typical 
absorption characteristics of carotenoid macular pigment (MP) 
(solid curve at left). The retinal pigment epithelium (RPE) of the 
retina was removed for this measurement, and the spectrum was 
measured through a 1 mm aperture. The tissue absorption is re­
markably similar in spectral shape to the absorption of a lutein/ 
zeaxanthin solution, including the appearance of vibronic ab­
sorption substructure. The solid curve at right shows the 
fluorescence spectrum of a solution of lutein, obtained under ex­
citation at 488 nm. (b) Molecular structure of lutein and zeaxan­
thin. (c) Energy level diagram of long-chain conjugated caro- 
tenoids such as lutein or zeaxanthin, with optical and 
nonradiative transitions indicated as arrows.
reseenee, since the excited lutein and zeaxanthin mol­
ecules relax very rapidly (within 200 -250  fs) to a lower 
lying excited state from which emission o f light is parity 
forbidden [see Fig. 1(e)], The unusual ordering of the en­
ergy states is a unique feature o f the polyenelike, 
ir-conjugated carotenoids having a large number o f conju­
gated C = C  double bonds [10 and 11 in lutein and zeax­
anthin, respectively; see Fig. 1(b)], In fact, the quantum 
efficiency for a radiative transition from the 2  ’ A g excited 
state to the 1 1 A g ground state is estimated to be as low as 
10- 5  to 10” 4 . 1 2  Therefore relaxation o f the excited mol­
ecule back to the ground state occurs mostly via nonradi­
ative transitions. The weak emission, observable only 
with very sensitive detection, has a small Stokes shift, 
and it occurs in the green wavelength range centered at 
—530 nm, as shown in Fig. 1.
Due to the weak fluorescence transitions, direct detec­
tion o f MP using lutein or zeaxanthin fluorescence has not 
been realized to date. However, the virtual absence o f in­
trinsic MP fluorescence makes it possible to detect in­
stead the resonance Raman transitions o f MP, even in liv­
ing human eyes , 1 1 ' 1 3  which would otherwise be masked 
beyond detection by the fluorescence background. Raman
detection methods have the benefit o f extremely high 
specificity for lutein and zeaxanthin, and therefore for MP 
(see below). However, detecting only the absolute amount 
of MP, the Raman response is attenuated to some degree 
by the combined absorption and scattering o f anterior 
ocular media, predominantly the lens . 1 1 ' 1 4 ' 1 5
One o f the MP imaging approaches is based on fundus 
reflectance techniques. There are two variants in which 
this method is implemented. In one variant, the reflec­
tance o f a broadband light source from the sclera is com­
pared for foveal and perifoveal spots, and the spectral 
contribution of the absorbance by MP is calculated. In a 
second variant, no reference at a peripheral site is 
needed. Only a foveal field is used, and MP levels are de­
rived from a model fit that takes into account the absorp­
tion and scattering coefficients o f all retinal layers tra­
versed in a double-patli succession by the light . 1 6 - 1 8  A 
review o f the technology can be found in Ref. 19. A  re­
cently developed state o f the art reflection device based on 
an imaging spectrograph, white light excitation source, 
and CCD camera detection, which performs single reflec­
tion measurements within a fraction of a second, with ad­
ditional cone-pliotoreceptor directionality, has been de­
scribed by Zagers et al.'20 Some reflectance-based imaging 
variants are based on scanning laser ophthalmoscopes 
(SLOs) . 21 Argon laser lines at 488 and 514 nm are used to 
generate monochromatic digital reflection images from 
the retina at MP “on peak” and “off peak” spectral absorp­
tion positions, which are then digitally subtracted to dis­
play the MP absorption distribution. Berendscliot and col­
leagues have compared direct reflectance and digital 
subtraction SLO methods in a lutein supplementation 
study2 2  and found that an SLO provided the most reliable 
data. They also found that MP optical density (O.D.) rises 
by approximately 5% per month in response to daily 
lutein supplementation. Using a modified confocal SLO, 
Wustemeyer et al. found reduced MP levels in AMD sub­
jects as compared with healthy subjects , 2 0  and Schweitzer 
et al. found that the effects o f lutein supplementation on 
MP levels could be tracked with SLO images generated by 
single-wavelengtli, 488 nm excitation . 2 4  Population stud­
ies employing reflectance techniques have reported sig­
nificantly varying results regarding MP levels, depending 
on the size o f the tested foveal fields, instrumental as­
pects, and tissue models used for data reduction. In a 
population study o f 159 subjects, measuring a foveal area 
of 2°, an average MP O.D. value o f 0.23 was found . 2 5  In 
another random population-based sample o f 435 subjects, 
with subjects older then 55 yr, measured over a 2.3° test 
field, an average MP O.D. level o f 0.33 was determined . 1 0  
In another large sample, involving 138 subjects and a 1.9° 
test field, an average MP O.D. level o f 0.48 was found . 19  
In all these studies no age effect was observed. While 
reflectance-based MP imaging is evolving as a viable clini­
cal technique for subjects of all ages, a drawback o f the 
technology is seen in the need for eyes in mydriasis . 1 9  The 
reasons for the large variations in average MP levels re­
main unclear.
A  further quantitative imaging technique for MP distri­
butions is based on resonance Raman spectroscopy . 1 1 ' 2 6  
This method detects the light that is Raman scattered 
from the MP carotenoid molecules at their 1525 cm ” 1
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C = C  double bond stretch frequency under resonant ex­
citation in the MP absorption band. The Raman method 
measures the response o f MP directly, has a very high 
molecule specificity, and has been validated by correlating 
Raman-image-derived MP distributions with HPLC- 
derived MP levels in excised human eye cups and living 
monkey eyes . 11 Very recently it has been possible to ex­
tend Raman imaging to living human eyes. Highly MP- 
specific digital Raman intensity maps can be obtained 
with high spatial resolution through undilated eyes 
within a fraction o f a second . 2 7  The validity o f in vivo 
methods used to measure MP is currently being debated 
in the literature . 1 4 ’ 1 5
2. MACULAR PIGMENT DETECTION BASED 
ON LIPOFUSCIN SPECTROSCOPY
In this work, we investigate the potential merits and 
drawbacks o f lipofuscin fluorescence spectroscopy (“auto­
fluorescence spectroscopy”), which appears to be yet an­
other promising approach for the quantitative detection 
and imaging o f MP. The method was first proposed some 
time ago by Delori, who used it to determine the inte­
grated single-path absorption o f MP . 2 8  A  comparison of 
the technique with nonimaging heterochromatic flicker 
photometry and reflectometry in a relatively large popu­
lation sample revealed reasonable correlations o f MP lev­
els, although there were significant and systematic 
differences . 2 5  Interestingly, the average MP optical den­
sity based on lipofuscin spectroscopy was 0.48 for a 2° test 
field, whereas reflectance techniques yielded only about 
half that value, 0.23, and the psychophysical technique 
gave a value in between, i.e., 0.37. Recently, the method 
has been expanded to an imaging configuration using a 
customized confocal SLO , 2 9 ,3 0  with measured test fields as 
large as 40°, and to an imaging configuration that uses a 
modified fundus camera coupled to a CCD camera . 31 All 
reported imaging studies had to be carried out with di­
lated pupils. Robson and co-workers, using 488 nm laser 
excitation and a short.-wavelength cutoff filter o f 521 nm 
in their lipofuscin-based measurements, compared the ob­
tained MP densities with MP levels measured with mo­
tion photometry for eight subjects . 2 9  They observed good 
correlation but found the lipofuscin-based MP levels to be 
a systematic factor o f 1.7 lower than the psychophysically 
derived levels. Most importantly, their study demon­
strated large intersubject. differences in macular pigmen­
tation in terms o f peak density, extent o f lateral distribu­
tion, and total amount. Furthermore, the authors 
demonstrated that large spatial MP distributions can 
lead to an underestimate o f MP levels in psychophysical 
methods if  the peripheral reference point is chosen too 
close to the fovea. Trieschmann and co-workers used a 
confocal SLO in combination with 488 nm laser excitation 
and 500 nm barrier filter detection, and they measured 
MP distributions in a large population sample including 
400 subjects with the age range 4 1 -9 0  yr . 3 0  They showed 
that subjects fall into one o f four classes o f MP distribu­
tions that are usable as a grading system. Due to differ­
ences in central and paracentral MP levels, total MP con­
centration decreases from type 1  to the other types. 
Importantly, these authors observed reduced levels o f MP
in a subgroup o f subjects having early AMD, showing ef­
fects such as drusen, retinal pigment epithelium (RPE) 
proliferation, and atrophy, and speculated that subjects 
with type 3 and 4 MP distributions may have increased 
risk for AMD development. However, questions remain 
about the measurement approach, since these authors did 
not justify the omission o f a measurement at a second ref­
erence wavelength that is not absorbed by the MP. Delori 
involved 38 subjects in his imaging study , 31 employing in 
his instrumentation dual-wavelength, broadband excita­
tion centered at 470 and 550 nm, respectively (FWHM 
—30 nm), and a barrier filter limiting lipofuscin emission 
to wavelengths above 590 nm. He found that lipofuscin- 
based methods using only one excitation wavelength 
(460 nm) would overestimate the MP levels by 0.22. Re­
garding age effects, he observed a slight increase o f MP 
levels with age. Recently, further SLO-based autofluores­
cence studies have been carried out by Wiistemeyer eton QQ 0,4
al., Hammer et al., and Schweitzer et al.
Human RPE contains the age pigment lipofuscin, 
which accumulates in the lysosomal body o f the RPE 
cells . 3 5  Two components o f lipofuscin exist that absorb 
strongly in the blue wavelength region and emit strongly 
in the orange-red region. They are two isomers o f a bis- 
substituted pyridinium ring, termed A2E and iso-A2E, 
respectively . 3 6  The structure o f the molecules, their opti­
cal transitions , 3 7  and their associated energy level scheme 
are shown in Fig. 2. The absorption spectrum o f A2E par­
tially overlaps with the absorption spectrum o f the macu­
lar carotenoids, and its emission spectrum is broad, ex­
tending to wavelengths well beyond the absorption o f 
carotenoids, as shown in Fig. 2. It is possible, therefore, to 
excite the A2E emission within and outside the absorp­
tion range o f MP. Similar to lutein and zeaxanthin, A2E 
has a conjugated carbon backbone. However, the conjuga­
tion length is shorter, interrupted by the central pyri­
dinium ring, which shortens the conjugated carbon bond 
chain to two smaller chains with five double bonds each. 
This leads to an emission with a quantum efficiency o f 
10- 2 , 3 7  which is about 3 orders o f magnitude stronger 
than that reported for lutein and zeaxanthin . 1 2  The in 
vivo excitation spectrum o f fundus autofluorescence is 
much broader than that o f A2E, suggesting that other li­
pofuscin fluorophores contribute to fundus 
autofluorescence . 3 8  Regarding its spatial distribution, the 
data o f Ref. 38 show that the lipofuscin fluorescence at 
15° from the fovea is 1.4-1.7 times higher than at the 
fovea and that there is a gradual increase in lipofuscin 
fluorescence with increasing eccentricity.
For indirect MP detection, the fluorescence o f lipofuscin 
is excited at two wavelengths: one wavelength that over­
laps both the MP and lipofuscin absorption and another, 
longer wavelength that lies outside the MP absorption 
range but that still excites the lipofuscin emission on the 
shoulder o f the lipofuscin absorption. The MP absorption 
can then be approximated from the difference in lipofus­
cin fluorescence intensities at foveal and perifoveal 
locations . 2 5 ’ 2 8  Imaging approaches have used laser excita­
tions that raster scan across the macula and beyond2 9 ,3 0  
or broadband excitation with beam diameters that are 
centered on the fovea and extend into the periphery . 31 MP 
optical density maps are usually generated by referencing
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Fig. 2. (a) Absorption and emission spectra of a methanolic so­
lution of A2E, the main fluorophore of lipofuscin, shown as solid 
curves at the left and right sides of the panel, respectively. The 
absorption transition between the lowest energy levels occurs in 
a broadband centered at 440 nm. Optical excitation leads to a 
strong emission centered at 660 nm. The overlapping absorption 
of MP is indicated as a dotted curve. The gray shaded area (X 
>700 nm) indicates the lipofuscin fluorescence range used for in­
direct detection and imaging of MP distributions, (b) Molecular 
structures of (left) A2E and (right) iso-A2E. (c) Energy level dia­
gram with optical transitions shown as arrows. Compared with 
carotenoids, the fluorescence transition is stronger in the A2E 
molecules due to their shorter conjugation length, which is inter­
rupted by the central pyridinium ring.
the MP levels in the macular region to a perifoveal refer­
ence point at about 7° eccentricity. Compared with MP 
Raman detection, which uses backscattering o f excitation 
light from the MP-containing Henle fiber layer, and there­
fore is not influenced by deeper retinal layers, lipofuscin- 
based MP detection has to use a light source in the deep 
RPE layer for that, purpose, and it has to take into ac­
count additional absorption and emission effects o f these 
layers and their fluorophores, as shown in Fig. 3(a).
As seen in resonance Raman detection experiments of 
MP, which detect the spectrally sharp C = C  double bond 
1525 cm - 1  stretching vibration Raman responses o f lutein 
and zeaxanthin (which occur at 527 nm under 488 nm ex­
citation), a strong fluorescence background is superim­
posed on the Raman response in the 530 nm region . 11 
This fluorescence background varies strongly from subject 
to subject and exceeds in strength the background level 
expected from intrinsic lutein or zeaxanthin (MP) fluores­
cence. This background is a combination o f lipofuscin 
fluorescence and fluorescence from anterior ocular media. 
In Raman detection, the broad fluorescence background 
can be easily fitted with a higher order polynomial and 
subtracted from the measured spectra. In lipofuscin- 
based MP measurements, however, these extra fluores­
cence responses can be expected to play an interfering
role. It is therefore essential to establish the merits and 
limitations o f the lipofuscin method.
The optical layers o f interest traversed by the excita­
tion light and the lipofuscin fluorescence are sketched in 
Fig. 3(b). The fluorescence intensity in 180° detection ge­
ometry, IDct, measured at a selected wavelength X in the 
visible/near IR wavelength range, is in general given by
( 1)
where T(X) is the transmission o f the respective layer cor­
responding to photoreceptors (PR), macular pigment 
(MP), and anterior ocular media (OM) at the fluorescence 
wavelength X. IL is the lipofuscin fluorescence originating 
in the fovea, and I omW  is the potentially overlapping 
fluorescence intensity o f the ocular media layer at X.
It is safe to assume that, the photoreceptors do not. gen­
erate any fluorescence, but. their absorption cannot, be ne­
glected, in general. Under excitation with Icxc at. wave­
length Xrar, the lipofuscin fluorescence intensity Il (\) is 
correlated with Icxc according to
Fig. 3. (a) Schematic representation of retinal layers participat­
ing in light absorption, transmission, and scattering of excitation 
and emission light in the macular region. ILM, inner limiting 
membrane; NFL, nerve fiber layer; HPN, Henle fiber, plexiform, 
and nuclear layers; PhR, photoreceptor layer; RPE, retinal pig­
ment epithelium. In Raman scattering, the scattering response 
originates from the MP, which is located anteriorly to the photo­
receptor layer. The influence of deeper fundus layers such as the 
RPE is avoided. In lipofuscin spectroscopy, light emission is gen­
erated from lipofuscin in the RPE layer to generate an intrinsic 
“light source” for single-path absorption measurements of ante­
riorly located MP layers. Using an excitation beam diameter ex­
ceeding the spatial extent of MP, the MP distribution can be 
quantified and spatially imaged (see the text), (b) Schematics of 
anterior optical media and retinal layers traversed by excitation 
laser light, fluorescence from anterior optical media, and fluores­
cence from lipofuscin. Iexc excitation light; IL, lipofuscin fluores­
cence; OM, ocular media; MP, macular pigment; PR, photorecep­
tors; RPE, retinal pigment epithelium; I0M, fluorescence from 
ocular media.
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exc? X) = rjL{\exo X )/ew(Xexc)T0M(\exc )71mp(X exc ) T p r ( \ ) ,
( 2)
and J0M is correlated with I exc according to
I(J\11 X , X ) VOSi ■ X ’ X  ^ 1 0A'I^  > (3 )
where %,(X,Xm.) and ^om^X.X^.) are the fluorescence 
quantum efficiencies, respectively, o f  lipofuscin and the 
anterior ocular media.
Inserting Eqs. (2) and (3) into Eq. (1), one obtains
W x exo X) = %ff(X exoX )/ew(Xere )Tom(Xexc w w x  exc) 
x  x ew) r 0JW( X )TMP( x ) r Pfi(x )
+ %>m(Xexo x ) / ew(x ew) [ i  -  r 0M(x )] .  (4 )
Referencing the transmissions o f the excitation light at 
the Xj and X2  positions to the transmission values in the 
peak o f the MP absorption band, 460 nm, with respective 
extinction coefficients K mp(\i) and KMP(\2), where
Ttrf(Xi) = 7tff(460)«^>, 7 * f(X 2) = T ^ U e O ) ^ 1,
the right side o f Eq. (6 ) reduces to 
[T^{p(460)/T^{p(460) f KMP<MhKMP,.x2)}^  w ith  o .D . = log (l/T ), 
and solving for the MP optical density difference, this can 
be written as
In general, it is impossible to extract the isolated MP 
transmission (absorption) from this complex relation be­
tween detector intensity and transmission/fluorescence 
terms o f all layers. However, adopting a string o f assump­
tions and approximations , 2 5  it becomes possible to elimi­
nate, in first order, several unwanted terms in Eq. (4) and 
to derive an approximation for the MP transmission (ab­
sorption) difference between fovea and perifovea.
First, as substantiated below (Section 3), it is possible 
to largely block the detection o f optical media fluorescence 
by limiting the detection o f lipofuscin fluorescence to near 
IR wavelengths. Only under this condition can the second 
term in Eq. (4) be ignored. Second, it is useful to reference 
the detected luminescence in the fovea to a measurement 
in the perifovea and to determine this ratio for two exci­
tation wavelengths Xi and X2  near the peak and just out­
side the MP absorption band, respectively. For the ratios 
o f the MP transmissions in perifovea and fovea at the two 
wavelengths one then obtains
O .D .m p(X 46o) -  O .D .Mp (X 460)
^Oe 2^,X)
rfMP{\ i,X) /  ^ /p (X 2,X) 
j  ?7mp(X2,X)_
7tff(Xi)7t;M(Xi)7t*(Xi) 
Tif f (X2) T‘om(X2) T‘pr(X2) 
7tff(X2) TgM(\.j.) 7pie(X2)
(5)
I f  one assumes that the lipofuscin composition is constant 
across the posterior pole, the quantum efficiency ratio 
term [ ^ fP(X1 ,X ) /^ fP(X1 ,X ) ] /[^ fp(X2 ,X ) /^ fp(X2 ,X)] is 
eliminated. I f  one further assumes that there is no differ­
ence between foveal and perifoveal lens transmissions, 
the lens transmission terms cancel out. Furthermore, if 
one ensures that the excitation light beam profiles are 
identical for the two wavelengths, they cancel out, too. 
One then obtains the much simplified expression
if^X^X) -log
M log
1 )  /  r m ( X 2 )
(7)
I f  one assumes in addition that the photoreceptors can be 
completely bleached in the measurements (TPR= 100%), 
the second term can be neglected. Then the MP optical 
density difference between fovea and perifovea is given by





i.e., it can be approximated by the log differences o f foveal 
and perifoveal fluorescence intensities.
It should be mentioned that besides lipofuscin detec­
tion at near IR wavelength, other approaches are possible 
to minimize the effects o f media fluorescence. These in­
clude confocal optics, separation o f excitation and detec­
tion beams through the lens, and correction for lens fluo­
rescence.
It is instructive to compare the derived expressions 
with the expression for the MP signal intensity obtained 
with the Raman method . 11 Since the Raman response 
originates directly in the MP layer, deeper layers do not 
play a role in the excitation and emission paths. Only the 
anterior optical media are traversed, resulting in
IS = I'oM^Kx^rI'oM^Raman (^E[)crRIexc(\exl)
+ %w(Xexc 5 ^ Raman )^exc ( ^ exc)[1 T(jM{ \jtun,u!l)]. (9)
Here, Ig is the Raman scattered light intensity, N(Ej ) is 
the concentration o f MP molecules, crR is the Raman scat­
tering cross section, and I exv is the laser excitation inten­
sity. No assumptions regarding photoreceptor bleaching 
have to be made, and since the fluorescence o f the lens is 
easily distinguishable from the spectrally sharp Raman
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response o f MP, it can be easily subtracted. On the other 
hand, since very little MP exists outside the macula area, 
foveal Raman measurements cannot be referenced to 
perifoveal levels, and lens absorptions as well as all ante­
rior media scattering will reduce the observed Raman 
intensities . 1 1 ,1 4 ,1 5
3. SINGLE-EXPOSURE MACULAR PIGMENT 
IMAGING—EXPERIMENTAL PROCEDURES 
AND VALIDATION TESTS
We based our MP measurements on an experimental con­
figuration involving direct, large diameter, laser excita­
tion o f a foveal and peripheral macular spot, using an im­
aging CCD camera for fluorescence detection . 3 9  The setup 
is shown schematically in Fig. 4. It is designed to maxi­
mize the throughput for fluorescence originating from the 
retina. Two fiber-coupled solid state lasers are sequen­
tially used as excitation sources. They operate at 488 and 
532 nm, respectively, and are controlled by a computer- 
interfaced mechanical shutter. At the fiber output, the la­
ser beams are expanded, collimated with an achromatic 
lens LI, filtered by a narrowband interference filter FI 
(FWHM —1 nm), and projected onto the retina using a 
lens L2, a dichroic holographic beam splitter BS1, and the 
human eye lens. The resulting excitation disk on the 
retina is —3.5 mm in diameter. The excitation disk has an 
intermediate focus at the position o f an aperture AP that 
is positioned in front o f the eye ( — 1  cm distance) and that 
effectively blocks spurious reflections originating from 
beam splitter BS1. To ensure steady fixation o f the eye 
during measurements, a red aiming laser is used as the 
fixation target. It is routed into the setup with an un­
coated quartz beam splitter BS2. The fixation light is di-
Fig. 4. Schematics of experimental setup used for imaging MP 
distributions in living human subjects. LI, L2, L3, lenses; FI, 
narrow bandwidth laser line filter; BS1, dichroic beam splitter; 
BS2, uncoated quartz beam splitter; AP, aperture; F2, F3, emis­
sion filters; CCD, charge-coupled detector array; PC, personal 
computer. A red aiming laser serves as a fixation target; depend­
ing on its direction, images can be recorded for either the macu­
lar region or the peripheral retina.
rected either to the fovea, for measurements centered on 
the fovea o f the macular region, or to the peripheral 
macula (—7° eccentricity). The fixation laser beam diam­
eter on the retina is —200 /un. The optical shutter is de­
signed such that it transmits a small portion o f the exci­
tation light even when it is closed. This allows the subject 
to view both the red fixation target and the superimposed 
laser excitation disk for optimum head alignment, which 
is further facilitated by an adjustable chin rest. At pro­
longed viewing, the leaked excitation light (6.9 log tro- 
lands) effectively bleaches more than 90% o f the photore­
ceptor pigments o f the macula. This establishes uniform 
background absorption throughout the exposed retina. 
The lipofuscin fluorescence is routed through beam split­
ter BS1, which is transparent for wavelengths above 
—580 nm, through holographic notch filter F2, which 
blocks excitation light wavelengths, and through a long- 
pass filter F3, which becomes transmissive above 700 nm. 
Limitation o f the fluorescence to wavelengths above 
700 nm ensures rejection o f light from unwanted fluoro- 
phores such as the lens and provides optimum contrast 
between peripheral and macular fluorescence intensities, 
as shown below. Finally, the signal is collected by a 
50 mm focal length achromat L3 and imaged onto the 
512x512  pixel array o f a CCD camera (Model ST-9 XE, 
Santa Barbara Instrument Group, Inc.). Individual pixel 
dimensions are 2 0  jU,m height by 2 0  /im  width; quantum 
efficiency in the red/near IR drops slowly from 60% at 
650 nm to 40% at 800 nm. The instrument is interfaced to 
a computer that controls the shutter and acquires data 
via software supplied by the camera manufacturer. For 
data analysis, the pixel intensity maps are converted to 
proportional files, and they are further processed with 
suitable image processing software (The MathWorks, 
Inc.). Measurements were performed with undilated eyes 
in a darkened room. Background noise levels were typi­
cally in the range o f 1 0 0  counts per pixel; signal counts 
typically amounted to —30,000 counts per pixel. The CCD 
camera temperature was kept at — 10 °C during mea­
surements. Laser speckle in the images was effectively re­
moved by mechanically shaking the light delivery fiber 
during measurements, which generates a spatially homo­
geneous laser excitation spot via fiber mode mixing. The 
resulting speckle removal effect is illustrated in Fig. 5 for 
images o f millimeter graph paper and the macular area o f 
a human retina, respectively, demonstrating that fine de­
tails such as small retinal blood vessels in the peripheral 
macula can be resolved. Since a 1 mm distance is imaged 
onto a pixel array distance o f 1 2 0  pixels, we estimate an 
— 1 0  jU,m spatial resolution under the used imaging condi­
tions after speckle removal.
For correct imaging o f large tissue regions, and for the 
purpose o f comparing MP measurements for single­
wavelength (488 nm) and dual-wavelength (488 and 
532 nm) measurements, intensity corrections have to be 
made that account for intensity variations o f the 
Gaussian-shaped laser beam profile and the resulting 
fluorescence response across the excitation spot. To illus­
trate this point, we imaged the lipofuscin distribution in 
the peripheral macula and in the foveal area by using an 
—3.5-mm-diameter excitation spot. As seen from Fig. 6 , 
the measured lipofuscin intensity distribution follows
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Fig. 5. Removal of laser speckle effects in fluorescence imaging, 
illustrated for [(a) and (b)J gray-scaled images o f millimeter 
graph paper and 1(c) and (d)J MP distributions. Granularity of 
images is removed in (b) and (d) when scrambling the excitation 
light via fiber mode mixing. This makes it possible to resolve fine 
details in the retinal images such as small retinal blood vessels 
at the periphery of the macula l(d)J. Calibrating the image di­
mensions with the known pixel array dimensions (1 mm equals 
120 pixels), we see that retinal blood vessels as thin as -2 0  fim 
can be clearly resolved in the used setup.
again a Gaussian beam profile, dropping for both wave­
lengths (488 and 532 nm) by —20% from the central in­
tensity level to a reduced level at the periphery of the 
fluorescence image. Thus fluorescence intensity levels at 
the edge o f the image disk have to be multiplied by a cor­
responding correction factor (—25% ) before comparing 
them with central image values. To eliminate the poten­
tial for any deviations from these profiles in living human 
eyes due to scattering and absorption effects o f the ante­
rior ocular media, we decided to image the lipofuscin dis­
tribution o f the retina in two specific locations. As 
sketched in Fig. 6 , one o f the two images is centered on 
the fovea. It is recorded for this centrally fixated subject 
such that a 7° eccentric location, termed S, is recorded 
along with the fovea, F. Subsequently, a second image is 
recorded, which is now centered on the same peripheral 
location S, achieved by having the subject fixate on the 
aiming laser that has been changed in direction by 7°. 
Since the spot S has an unchanging lipofuscin concentra­
tion, any detected difference in fluorescence intensities 
originating from the spot S in the two images has to be 
due to the laser excitation intensity beam profile plus the 
combination o f scattering and absorption effects o f ante­
rior ocular media. Comparing the corresponding intensi­
ties of the two images, we can easily derive a spatial cor­
rection factor map for each subject.
Laser power levels at the cornea were 2 mW during 
measurements; exposure times were 200 ms. At a retinal 
spot size of 3.5 mm diameter, the light exposure was thus 
about 3 m J/cm 2, which is approximately a factor o f 3 be­
low the photothermal safety limit o f 10 m J/cm 2  set forth
by the ANSI standard . 4 0  The photochemical limit for reti­
nal injury is listed in the same standard as 15.5 J /cm 2  for 
the used wavelengths. A t the used energy density o f 
3 m J/cm 2, the exposure is therefore a factor of —5000 be­
low the photochemical limit. Sequential measurements o f 
a subject at 488 and 532 nm could be carried out within a 
short measurement time o f about half a minute following 
eye/head alignment with the help o f a chin rest. The time 
interval between 488 and 532 nm image acquisition was 
about 2  min, allowing for fading of afterimages.
Typical retinal lipofuscin fluorescence images, “pixel in­
tensity maps I 4 3 3  and /532,” obtained at near IR wave­
lengths (X > 7 0 0  nm) from the macular region of the 
retina under 488 and 532 nm light, respectively, with the 
exposure conditions described above, are shown in Fig. 7. 
The two images differ substantially in the macular re­
gion, showing pronounced absorption due to MP under 
488 nm light and virtually no absorption under 532 nm 
light excitation, as expected from the MP absorption be­
havior (see Fig. 1). We used small blood vessel patterns in 
these images (see Fig. 7 and also Fig. 15 below) as land­
marks to align these two distributions for digital image 
processing. We use the lipofuscin fluorescence intensity 
map obtained under 532 nm excitation, / 532, to assess the 
distribution o f the lipofuscin and melanin concentration 
throughout the retinal area of interest, i.e., the area cen­
tered on the fovea and subtending to —7° eccentricity. 
This is the case since the / 5 3 2  intensities decrease from 
the macular image location with Im a x > 5 3 2  to the peripheral 
location with 5 3 2  by only the known correction factor
14  -7  0  7  14
Eccentricity (degree)
Fig. 6. Determination of spatial correction factor for image pro­
cessing due to spatially varying intensities in laser excitation 
and lipofuscin fluorescence disks, (a) Lipofuscin fluorescence in­
tensity in the peripheral retina, plotted versus distance along 
horizontal meridional line running through the center of a -3 .5  
-mm-diameter image disk (solid curve). The intensity profile has 
a good match to a Gaussian fit (dashed curve), as expected for the 
Gaussian intensity profile o f the exciting laser disk. At the edge 
o f the spot the intensity has dropped by -20%  with respect to the 
center of the profile. This value is used as a correction factor, (b) 
and (c) Schematics of central and peripheral retinal images re­
corded sequentially for measured eyes. In image (b), the excita­
tion disk is centered on the fovea F, and in image (c), it is cen­
tered on a spot S in the peripheral retina that is 7° eccentric. 
Spot S is visible in both images. Since the spot has a constant 
lipofuscin concentration, the fluorescence intensities originating 
from it in images (b) and (c) have to be due to the excitation in­
tensity profile, and the intensity difference can be used as a spa­
tial correction factor in the determination of MP levels from im­
age (b) or (c).
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Fig. 7. (a) White-light fundus camera image of a healthy subject 
(a), and lipofuscin fluorescence images of the fundus obtained at 
near IR wavelengths with (b) 488 nm and (c) 532 nm laser exci­
tation. Note the pronounced attenuation of fluorescence in the 
center of image (b) due to MP absorption and the nonattenuated 
fluorescence in image (c). Pixel intensity maps of images (b) and 
(c) are used for an indirect derivation of MP concentration levels 
existing in the macular region (see the text).
^Gauss (this factor is described above and is due to the com­
bined Gaussian laser excitation and fluorescence response 
profile).
Next, to derive the MP optical density in the fovea or 
surrounding regions, we use the measured lipofuscin fluo­
rescence intensity maps obtained under 488 and 532 nm 
excitation, respectively, to determine the MP optical den­
sity difference from Eq. (8 ), which becomes
(A n a xz—Jmin
( 10 )
where / max and / mjn are intensities averaged over certain 
pixel areas (see below). The factor 1.2 takes into account 
the ratio between the absorption o f MP at its maximum 
(460 nm) and the used excitation wavelengths o f 488 and 
532 nm. We determined this factor from the absorption 
spectrum o f MP measured from an excised eye cup . 11
For the calculation o f average MP levels in specific lo­
cations or along nasal-temporal and inferior-superior 
meridians, we group individual pixels into disks with a di­
ameter o f 20 pixels each, as illustrated in Fig. 8 . Averaged 
peripheral pixel intensities are determined from 1 2  pe­
ripheral pixel disks located on a circle with 7° eccentricity 
to the fovea, and the average pixel intensity in an area o f 
interest is determined from an additional, single disk po­
sitioned in that area, for example in the fovea, as shown 
in Fig. 8 .
To test our experimental setup and the image process­
ing routines, we imaged a tissue phantom in exactly the 
same geometry and under the same conditions as those
used for living eye measurements (180° detection geom­
etry with CCD camera detection), including identical light 
filtering and pixel processing. The tissue phantom con­
sisted o f a dried drop o f lutein solution spotted onto one o f 
the side windows o f a thin-walled cuvette filled with a 
methanolic A2E solution , 4 1  as illustrated in Fig. 9. The 
optical density o f the solution had a value o f 0.35 and 
488 nm. The dried lutein spot was roughly circular in di­
ameter (—2.5 mm) and had a nonuniform thickness and 
concentration that increased from the center outward. 
Using a small diameter (200 pan) 488 nm laser excitation 
spot, we imaged the lipofuscin fluorescence intensity o f 
the lutein spot/A2E solution combination, or the A2E so­
lution alone, progressing from the center o f the lutein 
spot toward the periphery and beyond. Simultaneously, 
we also measured the in situ sample transmissions at the 
laser wavelength, using a light chopper in the excitation 
laser beam, and phase-sensitive detection o f the transmit­
ted laser beam with a silicon photodetector placed behind 
the tissue phantom. From these measurements we were 
able to directly correlate lipofuscin-emission-based optical 
densities o f local lutein concentrations inside the phan­
tom spot with optical density values obtained from trans­
mission data. The results are displayed in Fig. 9 for a few 
dozen locations within the lutein spot. They demonstrate 
excellent agreement between the two methods (correla­
tion coefficient 2?=0.96), proving that the imaging proce­
dures and data processing routines lead indeed to the de­
sired lutein optical density determination for this tissue 
phantom.
Foveola
Fig. 8. Schematics showing processing of CCD pixel intensity 
regions to derive optical density values of MP absorption at any 
desired location in the retina. Individual pixels are grouped into 
disks with a diameter of 20 pixels each, and the intensities in 
these disks are averaged. One central disk is located at the cen­
ter of the macula, the faveola, with a resulting intensity 
Imin(ave). Twelve additional disks are chosen on a circle with 7° 
eccentricity to the foveola, with equidistant spacing, to calculate 
an average fluorescence intensity Imax(ave) in the periphery. The 
maximum MP image contrast, derived from these two averaged 
intensities, is proportional to the optical density of MP in the cen­
ter o f the macula, according to Eq. (10). Disks between the center 
and the peripheral circle (not shown) can be chosen to calculate 
the image contrast and MP at any eccentricity toward the periph­
eral retina.
O.D. = 1.2 X
/m ax
log z—
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Fig. 9. Measurement of lutein concentrations in a tissue phan­
tom consisting of a dried lutein spot located on the side wall of a 
thin cuvette filled with an optically thin A2E solution (O.D. 
-0.35). Optical densities of lutein concentrations were measured 
for several dozen positions within the lutein spot, using simulta­
neous lipofuscin fluorescence attenuation and transmission mea­
surements of the individual spots. The dried lutein spot in­
creased in thickness toward its periphery, thus providing a test 
sample with increasing strongly varying absorptions. Setup 
shown (a) schematically in side view and (b) from top. (c) Lutein 
optical densities measured with both techniques, showing excel­
lent correlation (correlation coefficient if  = 0.96). Transmission- 
based absorption levels had an accuracy of 2%; indirect, 
lipof'uscin-based absorption levels had an accuracy of 4%.
and 532 nm), and testing the effect on three subjects, we 
obtained the MP results shown in Fig. 10. The optical 
density values were computed with Eq. (10) and included 
correction o f the respective digital images for laser inten­
sity variations within the excitation disk (cqsuss). We ob­
serve enhancement factors o f 1.71, 1.72, and 1.85, respec­
tively, o f  the image contrast at wavelengths limited to 
700 nm and beyond, as compared with MP levels obtained 
when including fluorescence components in the b lu e- 
green spectral region. The variability o f the results in Fig. 
10 did not correlate with the age o f the subjects. To test 
whether the interfering green fluorescence component 
originates from intrinsic MP fluorescence (see Fig. 1 for 
the emission spectrum), we imaged an excised eye cup 
from a donor eye, using essentially the same imaging 
setup as that for living eyes. We obtained an MP O.D. 
value o f ~ 0 .4±  10% for this sample throughout the wave­
length range 530 -700  nm, thus revealing an absence o f a 
wavelength effect on the optical density This proves that 
intrinsic MP fluorescence is too weak to interfere with the 
obtainable image contrast o f the lipofuscin-fluorescence- 
based imaging technique. Next, we measured the wave­
length dependence for the foveal MP levels o f a subject 
having an implanted, nonfluorescing prosthetic eye lens. 
Again, we observed an absence o f a wavelength effect over 
the range 530 -700  nm. From these results we conclude 
that the artifactual green fluorescence present in living 
eyes originates from fluoropliores present in the living eye 
lens. For the purpose o f obtaining optimum image con­
trast and corresponding MP level determination, we find 
it important, therefore, to detect fluorescence levels only 
on the long-wavelengtli shoulder o f the lipofuscin fluores­
cence, i.e., above —700 nm. These experiments and re­
sults confirm similar conclusions by Delori et a / . 2 5  that de­
tection at long wavelengths (detection window centered at 
710 nm in his case) minimizes the effects o f secondary 
fluoropliores.
For the determination o f the MP optical density, the ob­
tained image contrast is obviously the key parameter, be­
ing directly proportional to the MP optical density In liv­
ing eyes, care must be taken that the lipofuscin 
fluorescence image contrast is not artifactually reduced or 
enhanced by absorbing or fluorescing compounds other 
than MP. For example, i f  an artifactual fluorescence sig­
nal existed in the macula, it would add to the fluorescence 
level o f lipofuscin and thus reduce the image contrast. 
Likewise, an extra fluorescence signal in the periphery, or 
an absorption in the center from unbleached photorecep­
tors, would enhance the image contrast. A  presence o f ar­
tifacts would be obvious if  there were to be a wavelength 
dependence o f the obtained image contrast, i.e., if  the im­
age contrast were to change depending on which spectral 
portions o f the lipofuscin fluorescence were included in 
the measurement and subsequent derivation o f the MP 
levels.
To check for the existence o f artifacts, we carried out a 
series o f measurements in which we limited the detected 
lipofuscin fluorescence signals to progressively longer 
wavelength regions. Using long-wavelengtli step function 
transmission filters with successively longer cut-on wave­
lengths with the two-wavelength measuring scheme (488
Fig. 10. Wavelength dependence of MP optical density obtained 
when successively limiting the detected fluorescence range to 
longer wavelengths, using long-wavelength pass filters with suit­
able cut-on wavelengths kc. The effect was measured for three 
subjects. Optimum image contrast and resulting maximum MP 
optical density are obtained when limiting the detection of lipo­
fuscin fluorescence to wavelengths A 3*700 nm. Note the strong 
reduction of MP optical density, caused by decreased image con­
trast when including green-yellow wavelengths. The effect is 
caused by artifactual emission signals in that wavelength region 
originating from the human lens.
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Fig. 11. Lipofuscin fluorescence images of four volunteer sub­
jects Ka)-(d)], obtained under 488 nm excitation, shown in gray 
scale. Fluorescence intensities are lowest in central dark image 
regions due to absorption of excitation light by MP. Note the pro­
nounced variation of MP distributions regarding strength, sym­
metry, and spatial extent among individuals.
Fig. 12. Lipofuscin fluorescence intensity profiles along nasal- 
temporal meridians (solid curves) and inferior-superior merid­
ians (dashed curves), all running through the center of the 
macula (see the inset). Plots are derived from pixel intensity 
maps of Fig. 8 for each of four subjects l(a)-(d)J. A transmission 
value in the foveola can be calculated from the averaged pixel in­
tensities in the peripheral macula and the foveola.
In Fig. 11 we show representative MP imaging results 
for four healthy volunteer subjects, labeled (a)-(d), with 
the obtained spatial MP distributions displayed as gray- 
scaled intensity levels with 16 bit accuracy. All experi­
ments were carried out with 488 and 532 nm imaging and 
corrected for spatial laser intensity variation over the ex­
citation disk (coauss)- In Fig. 12 intensity line plots are 
displayed that are derived from the gray-scale images for
each subject along nasal-tem poral and inferior-superior 
meridians, both running through the center o f the 
macula. In Fig. 13, the MP optical density data are plot­
ted for each subject along the nasal-tem poral meridian, 
and in Fig. 14, we display pseudocolor-scaled three­
dimensional MP distributions derived from the two­
dimensional gray-scaled intensity maps. In the line plots 
of Figs. 12 and 13, pixel intensities were averaged over
14 pixels (280 /un) oriented perpendicularly to the respec­
tive meridians, and transmission values were calculated 
versus distance from the fovea. For one o f the subjects, 
the MP distribution was imaged eight times over a period 
of four weeks, showing that the MP optical densities could 
be determined with a test-retest accuracy (standard de­
viation) o f 2.4%.
As can be clearly seen from Figs. 11-14, the spatial 
widths, symmetries, and concentrations o f MP vary sig­
nificantly among the four subjects. In subject (a), the MP 
distribution shows only a weakly enhanced central level 
compared with the parafovea. In subject (b), the MP dis­
tribution has a very low central level and is surrounded 
by a ring of MP. Subject (c) has a strongly peaked MP dis­
tribution in the center and almost no parafoveal levels, 
and subject (d) has both high central and parafoveal MP 
levels.
To investigate the influence of blood vessels on the spa­
tial MP asymmetries, we processed the measured pixel in­
tensity maps with reduced vertical pixel averaging, and 
with filter masks to enhance finer spatial details. Two 
gray-scale images and corresponding nasal-tem poral me­
ridional line plots illustrate the results. They are shown 
in Fig. 15. In the image shown at the top of the figure, the 
pixel intensity map is unfiltered. In the image shown at 
the bottom, the map is filtered and weighted with a 
Gaussian mask. For both images, resulting transmission 
line plots are shown, resulting from averaging over
15 pixels (solid curves) and 5 pixels (dashed curves), re­
spectively. Averaging o f 15 vertical pixels produces 
smooth curves but reveals pronounced asymmetries in 
the shoulders o f the distribution at —400 /im  eccentricity. 
Averaging of only 5 pixels results in a clearly visible spa­
Distance/jim Distance/|0,m
Fig. 13. MP optical density plot profiles along horizontal axis, 
derived from Fig. 11 for each subject.
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Fig. 14. Pseudocolor-scaled, three-dimensional MP distribution 
derived from two-dimensional lipofuscin fluorescence pixel inten­
sity maps of Fig. 8. Note the significant intersubject variations in 
MP levels, symmetries, and spatial extent.
(a) (c)
Fig. 15. Effect of blood vessels on transmission line plots de­
rived from gray-scale lipofuscin fluorescence intensity maps. Two 
lipofuscin fluorescence images are compared: (a) a standard gray­
scale image and (b) the same image convoluted with a mask fil­
ter, revealing finer details. For both images, nasal-temporal 
transmission plots are calculated and shown in (c) and (d), re­
spectively, for rectangular pixel areas of 5 pixels height and 
150 pixels width (dashed curves) and 15 pixels height and 
150 pixels width (solid curves). The appearance of small blood 
vessels on the order of -5 0  /xm diameter ( - 2  pixels) is clearly 
seen in the wings of the MP profile. The spatial asymmetry of the 
profile, however, is not influenced by the blood vessels. Note the 
small dip in absorption of MP in the faveola for this subject.
tial fine structure (—50 fim  width) in the shoulders o f the 
MP distribution, as evidenced by large amplitude oscilla­
tions in the profile in the —300-600  fim  eccentricity 
range. The overall spatial asymmetry o f the profile, how­
ever, is not influenced by the blood vessels. In the higher 
resolution plots, other spatial details not related to blood 
vessels are discernible, too, such as the small but clearly 
resolved dip o f the MP absorption profile in the foveola of 
this subject.
4. CLINICAL RESULTS
To further evaluate the lipofuscin-fluorescence-based MP 
imaging technique, we carried out a clinical population 
study involving 70 healthy volunteer subjects, recruited 
from ophthalmology clinics at the University o f Utah Mo­
ran Eye Center. All patients signed Institutional Review 
Board approved consent forms. The demographic charac­
teristics o f the patient population are shown in Table 1.
In Fig. 16 we display distinctive MP distribution pat­
terns observed in these subjects. We distinguish five cat­
egories, A -E , based on striking spatial features in the MP 
distributions. In category A, MP optical densities were 
very low (smaller than —0.05). This is observed for 11% of 
the population sample. In category B, the MP distribution 
is laterally extended and has enhanced central MP levels; 
it is seen in 22% o f the subjects. Category C features only 
a sharp central MP distribution, which is seen in 28% of 
the subjects. Category D has a sharp central MP distribu­
tion and an additional MP ring located in the parafovea; 
this pattern is seen in 17% o f the subjects and has been 
previously noted by other investigators using autofluores­
cence and reflectometry . 4 2  Finally, category E has a rela­
tively uniform, laterally extended MP distribution with 
no elevated central MP levels, a pattern seen in 12% of 
the subjects. We did not investigate a potential relation­
ship between the distribution types and age and gender, 
since this type o f analysis would ideally have a larger sub­
ject population to reach statistical significance.
For 20 o f the subjects, we recorded images for both 488 
and 532 nm excitation and evaluated the MP levels ac­
cording to Eq. (10). However, in all subjects an image con­
trast due to MP concentrations was practically absent un­
der 532 nm excitation. The images all looked very similar 
to that, shown in Fig. 7 and contributed at. most. 5% o f the 
contrast, relative to that, observed with 488 nm excitation. 
From this, we concluded that. 532 nm images are not. es­
sential for MP determinations in healthy subjects, and to 
facilitate rapid scanning o f this clinical population 
sample, we used only single-wavelength, 488 nm mea­
surements for the remaining subjects. It. is clear, though, 
that, two-wavelength imaging is required to achieve high­
est. accuracies, and it. is very likely to be required also for 
subjects with pathologies.
In Fig. 17, we display MP levels obtained for each sub­
ject. as a function o f age. For each subject, the data point, 
corresponds to a central MP level obtained by integrating 
the respective image over its foveolar region (150 /un di­
ameter). At. any age, there can be a large variation o f MP 
levels. In several subjects with age near 40 yr, for ex­
ample, the MP levels are seen to range from an O.D. near
Table 1. Demographics of the Population
Number of normal subjects 70
Age (yr: mean+SD) 53 + 16
Age range (yr) 23-89
Female (%) 50
Male (%) 50
Caucasian Subjects (%) 90
Nonsmokers (%) 86
Active smokers (%) 14
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Fig. 16. (a) Categories of MP distributions observed in clinical 
measurements of 70 subjects. Two examples are shown for each 
category. Category A has very low MP levels (O.D. smaller than 
0.05), B features enhanced central MP levels and lower eccentric 
levels, C has only a sharp, central MP distribution, D has a cen­
tral MP concentration surrounded by lower amounts arranged as 
a ring or shoulder, and E has both central and parafoveal MP lev­
els. (b) Distribution of 122 measured eyes among categories A-E. 
A large fraction of subjects, 28%, has a sharp, central MP 
distribution.
Fig. 17. MP levels measured in 90 eyes of a clinical population 
of 70 volunteer subjects, displayed as a function o f age. Each data 
point corresponds to the maximum MP level determined from li­
pofuscin fluorescence images. Note the significant variation of 
MP levels among individuals at any age and the average decline 
of levels with age. Solid circles represent subjects measured after 
cataract surgery (lens implant).
zero to an O.D. o f —0.6. Also, there is a statistically sig­
nificant decline of average MP levels with increasing age, 
with a correlation coefficient r= -0 .4 7 . Calculating the 
correlation coefficient with one data point per subject (one 
eye per subject), we obtain r= -0 .5 4 . The decline with age 
is similar to MP results obtained with resonance Raman
detection in previous Utah population studies studies1 1 ,4 3  
and in an Irish study4 4  but differs from other previous re­
ports, which also used autofluorescence imaging . 2 5 ,3 2
Finally, we investigated the correlation of the indirect, 
lipofuscin-fluorescence-based MP detection technique 
with the direct technique o f integral resonance Raman de­
tection, the latter measuring MP responses over a
— 1 .2 -mm-diameter excitation spot in an integral 
fashion . 11 For this purpose we recruited a clinical popula­
tion subgroup of 48 subjects and measured 72 eyes. The 
results are shown in Fig. 18, revealing a statistically sig­
nificant and strong correlation between both methods 
(correlation coefficient r=0.73, p <  0.0001, including all 
eyes measured; a n d r= 0 .75 ,p < 0 .0001 , including only one 
eye per subject). Solid circles in Fig. 18 correspond to data 
points for subjects with lens implants. Limiting the corre­
lation to MP optical densities below —0.35, the correlation 
is even stronger. At optical densities above —0.35, the 
variance o f the levels increases, likely caused by break­
down o f the assumptions underlying the lipofuscin-based 
MP detection method and the resonance Raman methods.
5. CONCLUSION
Detection of lipofuscin fluorescence, in combination with 
suitable signal processing, appears to be a viable noiiiii- 
vasive objective optical method that is well suited to indi­
rectly derive the concentrations and spatial distributions 
of MP in living human subjects, at least in subjects that 
are free from macular pathologies. Since the method is 
not highly molecule specific, care must be taken to elimi­
nate confounding effects of fluoropliores in the detected
Fig. 18. Correlation between MP levels determined by 
lipofuscin-fluorescence-based imaging and resonance Raman 
spectroscopy. 72 eyes of 48 subjects were measured for these ex­
periments. Fluorescence-based MP optical density levels are 
maximum levels at the foveola, calculated from lipofuscin fluo­
rescence pixel intensity maps integrated and averaged for a cir­
cular area, centered at the fovea, having 20 pixel diameter 
(150 /an). Raman-based MP levels are derived from Raman scat­
tered light intensities at the carbon double stretch frequency of 
1525 cm '1. Since the latter are obtained with a 1-mm-diameter, 
488 nm laser, excitation spot centered on the macula, Raman- 
based MP levels are averaged over a 1-mm-diameter area. A re­
markably high correlation (correlation coefficient r= 0.73) is ob­
tained between both methodologies. Raman-based levels are not 
corrected for media opacities, while fluorescence-based levels are 
not influenced by media opacities. The high correlation therefore 
demonstrates indirectly that media opacities are not very signifi­
cant in Raman measurements.
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intensity maps. We show that confounding effects can 
originate from fluorophores in the living human lens, 
which under simultaneous excitation with the lipofuscin 
molecules generate a strong fluorescence in the green- 
yellow wavelength range. The confounding effect on the 
optically detected MP levels can be avoided by using a 
transmission filter in the fluorescence detection channel 
that limits the detection to wavelengths on the long- 
wavelength shoulder o f the lipofuscin fluorescence spec­
trum. Using a direct, CCD-based fluorescence imaging 
setup with laser excitation and filtered signal detection, 
we demonstrate that it is possible to measure MP distri­
butions within a fraction o f a second through undilated 
eyes with high reproducibility. MP measurements o f a 
population sample involving 70 healthy subjects reveal 
distinct patterns o f MP distributions, such as a pattern 
with high central MP levels surrounded by eccentric 
shoulders or rings o f lower MP levels. Most import antly, it 
is seen that MP levels can differ very strongly among in­
dividuals, i.e., by more than 1 order o f magnitude, and 
that the average MP levels decline slowly with age in the 
sampled population (on average by a factor o f 3 between 
ages 25 and 80).
Our results also show that a single-wavelength, 
488 nm laser exposure is adequate to determine the MP 
levels with —95% accuracy. For most practical purposes it 
is therefore not necessary to use an additional excitation 
wavelength outside the MP absorption range for MP level 
determinations. However, in the presence o f macular pa­
thology, it is very likely that dual-wavelength measure­
ments will be necessary to account for spatially nonuni­
form lipofuscin and melanin distributions. The 
fluorescence-based MP detection method shows a statisti­
cally significant correlation with MP measurements using 
highly MP-specific resonance Raman spectroscopy in 
healthy subjects, as seen from a direct comparison of both 
techniques in a subgroup o f 48 subjects. MP levels showed 
a tight, correlation up to integrated MP optical density 
levels o f —0.35. At. higher MP levels, deviations occur that, 
are likely correlated with nonlinear effects o f both optical 
methods at. higher MP levels. Possible factors include (a) 
screening effects in the MP Raman and lipofuscin fluores­
cence responses at. high molecule concentrations, (b) an 
undersampling o f the MP distributions caused by lens 
opacity effects in elderly subjects in the Raman method, 
(c) nonvanishing MP levels at. the peripheral retinal ref­
erence point, in the fluorescence-based method, and (d) re­
sidual absorption o f photoreceptors in the fluorescence de­
tection. We expect, further insight, into the differences 
between both methods by a direct, comparison of 
fluorescence-based imaging results with Raman images of 
MP distributions in the same subjects.
Since the fluorescence-based MP detection method is 
not. influenced, in first, order, by anterior media opacities, 
it. could have an advantage over the Raman method in 
elderly subjects, who in general have higher lens opacities 
and, according to our clinical results, also reduced MP lev­
els. The age-related decline o f MP levels confirms our ear­
lier results obtained with the Raman detection method, 
although the magnitude o f the decline is slightly higher in 
the Raman results (decline by a factor o f about. 5 between 
ages 25 and 80). In principle, this difference is not. sur­
prising, since the Raman response measures absolute MP 
levels and therefore is reduced by media opacities. On the 
other hand, the difference is very small, and therefore 
these comparative results show that, lens opacities gener­
ate only small optical densities in the blue-green wave­
length range. This is in agreement, with recent, literature 
data showing that, lens optical density values are close to 
zero for all ages at. wavelengths above —500 nm,45 sub­
stantially less than earlier studies had reported.46,47 It. re­
mains unclear why the age-related decline o f MP levels 
has not. been observed by other groups using the 
lipofuscin-based MP detection method.29-31 Potential ex­
planations are that, the confounding effects o f lens fluores­
cence have not. been adequately considered in those stud­
ies or that, there are systematic differences in the 
population samples. Age-related declines in MP are con­
sistently detected in our Utah population by three differ­
ent. methods— autofluorescence imaging, resonance Ra­
man detection,11 and heterochromatic flicker 
photometry43 so our discordant, findings are likely related 
to subject, recruitment, and selection factors rather than 
methodological differences.
In summary, spatial and quantitative information o f 
retinal MP levels simultaneously measurable with the 
lipofuscin-based technique without, pupil dilation can be 
expected to be o f tremendous value in screening o f large 
populations. It. will provide a viable tool in studies inves­
tigating the influence o f dietary supplements on MP lev­
els and their distributions and in research investigating 
the link between MP levels and retinal pathologies.
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